Feds tell pharma companies to pony up 340B discounts, but it’s unclear whether they will esagonowsky Tue, 01/05/2021 […]

Goodbye pill, hello science: Pfizer debuts redesigned logo with double helix design bbulik Tue, 01/05/2021 – 10:20

Reminisce about good timesHelen Garr, deputy director of NHS Practitioner Health, says, “Many of us will be greeting […]

The effect of the prescription opioid crisis in North America is well documented.1 In 2018 some 68 500 […]

In their impressive meta-analysis, Cheng and colleagues find no meaningful evidence for the impact of psychosocial interventions that […]

New Innovative Licensing and Access Pathway launched

The total value of all payments for the Atacand brand is $400m

Company is aiming for approval in the adjuvant setting

Key focus of the deal is focal-onset seizure treatment cenobamate

Updated Date: Mon, 28 Dec 2020 00:00:00 EST